Skip to content
healthcare.dev

DOXIL

NDC 0338-9665, doxorubicin hydrochloride, injection, suspension, liposomal, from Baxter Healthcare Corporation.

Product NDC
0338-9665
Status
Listed
Labeler
Baxter Healthcare Corporation
Dosage form
INJECTION, SUSPENSION, LIPOSOMAL
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA050718
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0338-9665 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXORUBICIN HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
0338-9665-01003389665011 VIAL, SINGLE-DOSE in 1 CARTON (0338-9665-01) / 25 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/917eddf9-1d3f-4abe-8c81-d33b066e5bae
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0338-9665

Use it

Look up 0338-9665 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0338-9665 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0338-9665. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.